Identification of a New Subfamily of HNH Nucleases and Experimental Characterization of a Representative Member, HphI Restriction Endonuclease
Overview
Affiliations
The restriction endonuclease (REase) R. HphI is a Type IIS enzyme that recognizes the asymmetric target DNA sequence 5'-GGTGA-3' and in the presence of Mg(2+) hydrolyzes phosphodiester bonds in both strands of the DNA at a distance of 8 nucleotides towards the 3' side of the target, producing a 1 nucleotide 3'-staggered cut in an unspecified sequence at this position. REases are typically ORFans that exhibit little similarity to each other and to any proteins in the database. However, bioinformatics analyses revealed that R.HphI is a member of a relatively big sequence family with a conserved C-terminal domain and a variable N-terminal domain. We predict that the C-terminal domains of proteins from this family correspond to the nuclease domain of the HNH superfamily rather than to the most common PD-(D/E)XK superfamily of nucleases. We constructed a three-dimensional model of the R.HphI catalytic domain and validated our predictions by site-directed mutagenesis and studies of DNA-binding and catalytic activities of the mutant proteins. We also analyzed the genomic neighborhood of R.HphI homologs and found that putative nucleases accompanied by a DNA methyltransferase (i.e. predicted REases) do not form a single group on a phylogenetic tree, but are dispersed among free-standing putative nucleases. This suggests that nucleases from the HNH superfamily were independently recruited to become REases in the context of RM systems multiple times in the evolution and that members of the HNH superfamily may be much more frequent among the so far unassigned REase sequences than previously thought.
Zhu X, Mou C, Zhang F, Huang Y, Yang C, Ji J Rice (N Y). 2020; 13(1):45.
PMID: 32654074 PMC: 7354284. DOI: 10.1186/s12284-020-00407-2.
Systematic classification of the His-Me finger superfamily.
Jablonska J, Matelska D, Steczkiewicz K, Ginalski K Nucleic Acids Res. 2017; 45(20):11479-11494.
PMID: 29040665 PMC: 5714182. DOI: 10.1093/nar/gkx924.
Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
Gholizadeh P, Aghazadeh M, Asgharzadeh M, Kafil H Eur J Clin Microbiol Infect Dis. 2017; 36(11):2043-2051.
PMID: 28601970 DOI: 10.1007/s10096-017-3036-2.
Type II restriction endonucleases--a historical perspective and more.
Pingoud A, Wilson G, Wende W Nucleic Acids Res. 2014; 42(12):7489-527.
PMID: 24878924 PMC: 4081073. DOI: 10.1093/nar/gku447.
Rosenkrantz J, Aarts H, Abee T, Rolfe M, Knudsen G, Nielsen M BMC Microbiol. 2013; 13:294.
PMID: 24345035 PMC: 3878590. DOI: 10.1186/1471-2180-13-294.